Healthtech Growth Investors & VC Firms
1213 firms in this list, with a median first check of $1.1M. 281 of them lead rounds. Generated from verified public data and updated continuously.
Keensight Capital
ParisGrowth–Late Stage$10M – $800M
2 people
Bamboo Capital Partners
LuxembourgSeed–Growth
22 people
Bonitás Ventures
BudapestSeries A–Late Stage$540K – $4.3M
19 people
Teralys Capital
MontrealGrowth
22 people
WELL Ventures
VancouverSeed–Growth
16 people
LYFE Capital
Menlo ParkSeed–Late Stage
17 people
New Science Ventures
GreenwichSeed–Late Stage$2M – $8M
7 people
GroundForce Capital
VeniceSeed–Late Stage$10M – $35M
9 people
New Mountain Capital
New YorkGrowth
6 people
Danone Manifesto Venture
New York CitySeed–Growth
11 people
Minerva Growth Partners
TokyoGrowth–Late Stage$6.7M – $20M
14 people
Pemba Capital Partners Pty Ltd.
SydneyGrowth–Late Stage$6.6M – $19.8M
7 people
Wittington Ventures
TorontoSeed–Late Stage
13 people
CTI Life Sciences Fund L.P.
MontréalSeed–Late Stage
9 people
Northlane Capital Partners
BethesdaGrowth$25M – $150M
Pharos Capital Group
DallasGrowth–Late Stage$25M – $50M
18 people
Phatisa
BambouGrowth–Late Stage
15 people
Prysm Capital
San FranciscoGrowth–Late Stage
15 people
Puhua Capital
HangzhouPre-Seed–Late Stage$1.4M – $112M
Cowin Capital Group
ShenzhenSeed–Late Stage$1.4M – $50M
11 people
Unison Capital
TokyoGrowth–Late Stage
5 people
Remgro / Invenfin ecosystem
StellenboschSeed–Growth
16 people
Bioventures Investors
WestboroughSeed–Late Stage$15M – $100M
15 people
Cohen Circle
New YorkPre-Seed–Late Stage
12 people
Related lists
Growth Investors & VC Firms (4757)Healthtech Investors & VC Firms (3208)Healthtech Seed Investors & VC Firms (2488)Healthtech Series A Investors & VC Firms (2210)Healthtech Investors & VC Firms in United States (1616)Growth Investors & VC Firms in United States (1502)Growth Investors & VC Firms in Global (1414)Healthtech Pre-Seed Investors & VC Firms (1328)Healthtech Series B Investors & VC Firms (1216)Enterprise Software Growth Investors & VC Firms (1186)
Data sourced from public filings and firms' own websites — see our methodology.






























































